Neural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.
The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.
Dermatologists need to be aware of margin of error and related issues that can affect the results of biosimilar clinical trials, a study shows.
What exciting new devices, drugs and treatments will the New Year bring dermatologists and their patients? Physicians in the specialty and others share what they most anticipate in the coming year.
The dermatology community experienced big strides in medical and cosmetic dermatology in 2017. Dermatologists share what they think were major breakthroughs throughout the year.
In this installment of our melanoma case studies series, we focus on common cancers in unusual locations versus uncommon cancers in classic locations.
The holidays can be stressful, but rest assured, you can get through them with peace and joy instead of tension and oy vey. It just takes some mindfulness.
Weren’t we all preparing for the holidays in 2016 about a week ago? Time flies when you’re helping patients. To that end, we asked dermatologists to reflect on 2017, and summarize it using just one word (or two) with a brief explanation.
With the internet being available at everyone's fingertips and seemingly endless advertising for a variety of skincare and cosmetic products, the average patient may come to an appointment with misinformation and questions.
Thinking of psoriasis and atopic dermatitis as a spectrum, rather than separate diseases might lead to better understanding, and potentially better treatments.
A retrospective study shows that early propranolol-induced heart rate reductions fail to predict clinical response of infantile hemangiomas.
Ocular comorbidity risk is already high in patients with atopic dermatitis and may increase even further as biologic agents are introduced, a study shows.
ISSVA clinical classifications aren't enough to accurately identify vascular malformation subtypes, according to a recent review.
Adult AD may be influenced by childhood eczema, though most adults have no memory of childhood eczema.
A retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.
Survey highlights the challenges of controlling psoriasis flares.
Environmental and lifestyle factors, such as certain foods and infections, may trigger onset of psoriasis and account for approximately 30% of the risk of the condition in people with a genetic preposition, research presented in London shows.
Psoriasis has long been linked with poor nutrition, high body mass index and metabolic disorders. New research suggests a reduced sense of taste and smell, caused by inflammation, may explain why.
Psoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.
The spleen may have a role in driving the higher rate of cardiovascular disease seen in psoriasis patients through a spleen–atherosclerotic axis, suggests research presented at a meeting in London.
Pooled meta-analysis does not support association between isotretinoin treatment for acne and worsening of depression.
A lower level concentration of ingenol mebutate gel for the chest significantly reduces actinic keratosis lesion counts without severe side effects, a study shows.
The lack of serious laboratory abnormalities in patients on isotretinoin suggests that reduced monitoring may suffice.
We know you love a good diagnostic challenge. Can you solve these 6 cases that we've featured over the past year?
Switching from adalimumab to etanercept or vice versa after interruption can improve treatment response, data presented in London suggests.
Phase three trials of the selective IL-23 blocker risankizumab are replicating the promising results achieved by phase two trials for psoriasis, researchers report in London.
Secukinumab has been shown to be effective for the treatment of moderate-to-severe plaque psoriasis in hard-to-treat patients who failed anti-TNFa treatment, researchers report in London.
As the field of medicine becomes more complex, so do the legal questions that can mean the difference between a lawsuit with a positive result and one with a negative result. Dr. Goldberg looks at 5 potential situations and offers his advice.
Adding caffeine to topical skin treatments would be a simple way to reduce inflammation in patients with atopic dermatitis and psoriasis, suggests a review presented at the Psoriasis: From Gene to Clinic International Congress, which took place in London this week.
Dr. Nice performed a series of IPL procedures on a male patient for facial redness. With each subsequent treatment, the patient became increasingly unhappy and belligerent. The patient demanded a refund saying Dr. Nice's family and staff would regret it if one was not provided. What can he do?